Chromatin Deregulation in Cancer

Chromatin Deregulation in Cancer

ISBN-10:
1621821404
ISBN-13:
9781621821403
Pub. Date:
05/31/2017
Publisher:
Cold Spring Harbor Laboratory Press
ISBN-10:
1621821404
ISBN-13:
9781621821403
Pub. Date:
05/31/2017
Publisher:
Cold Spring Harbor Laboratory Press
Chromatin Deregulation in Cancer

Chromatin Deregulation in Cancer

Hardcover

$33.75
Current price is , Original price is $33.75. You
$33.75 
  • SHIP THIS ITEM
    In stock. Ships in 1-2 days.
  • PICK UP IN STORE

    Your local store may have stock of this item.


Overview

The human genome is packaged into chromatin, which is composed of numerous proteins that help control gene expression, DNA replication and repair, and genome stability. In recent years, it has become clear that the deregulation of chromatin structure plays an important role in numerous cancers.

Written and edited by experts in the field, this collection from Cold Spring Harbor Perspectives in Medicine examines the chromatin components that are commonly mutated, what is understood about the mechanisms that lead to hematological malignancies and solid tumors, and prospects for the therapeutic modulation of chromatin. The contributors describe how histone proteins, histone-modifying enzymes, chromatin remodelers, transcriptional regulatory complexes, enhancer-associated factors, and signaling proteins are dysregulated in cancer pathogenesis. In addition, the roles of DNA methylation and noncoding RNAs are covered.

The authors also discuss small molecules and other drugs that are currently under development or already used to treat cancer (e.g., HDAC inhibitors and DNA hypomethylating agents). This book is therefore essential reading for all cancer biologists, cell and molecular biologists, and pharmacologists interested in understanding cancer therapies.

Product Details

ISBN-13: 9781621821403
Publisher: Cold Spring Harbor Laboratory Press
Publication date: 05/31/2017
Pages: 382
Product dimensions: 10.20(w) x 7.20(h) x 0.90(d)

Table of Contents

Preface

Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer
Anne Laugesen, Jonas Westergaard Højfeldt, and Kristian Helin

The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer
Richard L. Bennett, Alok Swaroop, Catalina Troche, and Jonathan D. Licht

Mixed-Lineage Leukemia Fusions and Chromatin in Leukemia
Andrei V Krivtsov, Takayuki Hoshii, and Scott A. Armstrong

Oncogenic Mechanisms of Histone H3 Mutations
Daniel N. Weinberg, C. David Allis, and Chao Lu

MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer
Christie C. Sze and Ali Shilatifard

The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer
Courtney Hodges, Jacob G. Kirkland, and Gerald R. Crabtree

DNMT3A in Leukemia
Lorenzo Brunetti, Michael C. Gundry, and Margaret A. Goodell

TET2 in Normal and Malignant Hematopoiesis
Robert L. Bowman and Ross L. Levine

Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer
Narsis Attar and Siavash K. Kurdistani

The Role of Additional Sex Combs-Like Proteins in Cancer
Jean-Baptiste Micol and Omar Abdel-Wahab

SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation
Catherine C. Fahey and Ian J. Davis

ATRX and DAXX: Mechanisms and Mutations
Michael A. Dyer, Zulekha A. Qadeer, David Valle-Garcia, and Emily Bernstein

The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer
Alea A. Mills

Cohesin Mutations in Cancer
Magali De Koninck and Ana Losada

HDACs and HDAC Inhibitors in Cancer Development and Therapy
Yixuan Li and Edward Seto

DNA Hypomethylating Drugs in Cancer Therapy
Takahiro Sato, Jean-Pierre J. Issa, and Patricia Kropf

Targeting Cancer Cells with BET Bromodomain Inhibitors
Yali Xu and Christopher R. Vakoc

Histone Lysine Demethylase Inhibitors
Ashwini Jambhekar, Jamie N. Anastas, and Yang Shi

Mechanisms of Nucleosome Dynamics In Vivo
Steven Henikoff

Nonhistone Lysine Methylation in the Regulation of Cancer Pathways
Scott M. Carlson and Or Gozani

Long Noncoding RNAs: At the Intersection of Cancer and Chromatin Biology
Adam M. Schmitt and Howard Y. Chang

Index
From the B&N Reads Blog

Customer Reviews